{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:45:22Z","timestamp":1784609122080,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81430081"],"award-info":[{"award-number":["81430081"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.intimp.2020.106211","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T13:03:41Z","timestamp":1579525421000},"page":"106211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Anti-tumor immune response varies among individuals: A gene expression profiling of mouse melanoma"],"prefix":"10.1016","volume":"80","author":[{"given":"Xiaoyue","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingcheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6184","key":"10.1016\/j.intimp.2020.106211_b0005","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1126\/science.1251102","article-title":"Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer","volume":"344","author":"Tran","year":"2014","journal-title":"Science"},{"issue":"7549","key":"10.1016\/j.intimp.2020.106211_b0010","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature"},{"issue":"7662","key":"10.1016\/j.intimp.2020.106211_b0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"issue":"7662","key":"10.1016\/j.intimp.2020.106211_b0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2020.106211_b0025","first-page":"1","article-title":"Melanoma\u2013clinical, dermatoscopical, and histopathological morphological characteristics","volume":"22","author":"Situm","year":"2014","journal-title":"Acta Dermatovenerol. Croat."},{"key":"10.1016\/j.intimp.2020.106211_b0030","doi-asserted-by":"crossref","first-page":"14343","DOI":"10.1038\/ncomms14343","article-title":"Microenvironment-derived factors driving metastatic plasticity in melanoma","volume":"8","author":"Kim","year":"2017","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.intimp.2020.106211_b0035","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1158\/2159-8290.CD-13-0005","article-title":"Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2","volume":"3","author":"O'Connell","year":"2013","journal-title":"Cancer Discov"},{"issue":"21","key":"10.1016\/j.intimp.2020.106211_b0040","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1073\/pnas.1602069113","article-title":"NLRC5 MHC class I transactivator is a target for immune evasion in cancer","volume":"113","author":"Yoshihama","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"26","key":"10.1016\/j.intimp.2020.106211_b0045","doi-asserted-by":"crossref","first-page":"22857","DOI":"10.18632\/oncotarget.3127","article-title":"Macrophage depletion reduces postsurgical tumor recurrence and metastatic growth in a spontaneous murine model of melanoma","volume":"6","author":"Tham","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.intimp.2020.106211_b0050","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00262-011-1172-6","article-title":"An immune-active tumor microenvironment favors clinical response to ipilimumab","volume":"61","author":"Ji","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"issue":"11","key":"10.1016\/j.intimp.2020.106211_b0055","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nm.3391","article-title":"Tumor metastasis: moving new biological insights into the clinic","volume":"19","author":"Wan","year":"2013","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.intimp.2020.106211_b0060","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.intimp.2020.106211_b0065","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/ng.3581","article-title":"Landscape of tumor-infiltrating T cell repertoire of human cancers","volume":"48","author":"Li","year":"2016","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.intimp.2020.106211_b0070","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nbt.3147","article-title":"Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice","volume":"33","author":"Obenaus","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"D1","key":"10.1016\/j.intimp.2020.106211_b0075","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The Immune Epitope Database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"7528","key":"10.1016\/j.intimp.2020.106211_b0080","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nature14001","article-title":"Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing","volume":"515","author":"Yadav","year":"2014","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2020.106211_b0085","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan- 4.0: improved peptide-MHC Class I interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106211_b0090","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/imm.12889","article-title":"Improved methods for predicting peptide binding affinity to MHC class II molecules","volume":"154","author":"Jensen","year":"2018","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.intimp.2020.106211_b0095","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1158\/2326-6066.CIR-19-0155","article-title":"Machine-learning prediction of tumor antigen immunogenicity in the selection of therapeutic epitopes","volume":"7","author":"Smith","year":"2019","journal-title":"Cancer Immunol Res."},{"issue":"1","key":"10.1016\/j.intimp.2020.106211_b0100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106211_b0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13059-017-1156-8","article-title":"Genome-wide analysis of differential transcriptional and epigenetic variability across human immune cell types","volume":"18","author":"Ecker","year":"2017","journal-title":"Genome Biol."},{"issue":"5","key":"10.1016\/j.intimp.2020.106211_b0110","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41588-018-0086-z","article-title":"Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets","volume":"50","author":"Wedge","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2020.106211_b0115","doi-asserted-by":"crossref","DOI":"10.1177\/1176935118805398","article-title":"Cross-cancer prediction: a novel machine learning approach to discover molecular targets for development of treatments for multiple cancers","volume":"17","author":"Gao","year":"2018","journal-title":"Cancer Inform."},{"key":"10.1016\/j.intimp.2020.106211_b0120","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3389\/fimmu.2018.01286","article-title":"seq-ImmuCC: cell-centric view of tissue transcriptome measuring cellular compositions of immune microenvironment from mouse RNA-Seq Data","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2020.106211_b0125","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.intimp.2020.106211_b0130","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"issue":"1","key":"10.1016\/j.intimp.2020.106211_b0135","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol. Evol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106211_b0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.intimp.2020.106211_b0145","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","article-title":"Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses","volume":"169","author":"Lavin","year":"2017","journal-title":"Cell"},{"issue":"7471","key":"10.1016\/j.intimp.2020.106211_b0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2020.106211_b0155","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/nar\/gkp896","article-title":"KEGG for representation and analysis of molecular networks involving diseases and drugs","volume":"38","author":"Kanehisa","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.intimp.2020.106211_b0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.intimp.2020.106211_b0165","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrc3670","article-title":"Tumour antigens recognized by T lymphocytes at the core of cancer immunotherapy","volume":"14","author":"Coulie","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"5838","key":"10.1016\/j.intimp.2020.106211_b0170","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1144830","article-title":"Regulation of homeostatic chemokine expression and cell trafficking during immune responses","volume":"317","author":"Mueller","year":"2007","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.intimp.2020.106211_b0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1158\/1541-7786.MCR-04-0189","article-title":"Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation","volume":"3","author":"Creighton","year":"2005","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2020.106211_b0180","doi-asserted-by":"crossref","first-page":"e1267892","DOI":"10.1080\/2162402X.2016.1267892","article-title":"Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis","volume":"6","author":"Putz","year":"2017","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.intimp.2020.106211_b0185","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41591-019-0382-x","article-title":"Genomic correlates of response to immune checkpoint blockade","volume":"25","author":"Keenan","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2020.106211_b0190","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav4474","article-title":"Adaptive mutability of colorectal cancers in response to targeted therapies","author":"Russo","year":"2019","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.intimp.2020.106211_b0195","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.4049\/jimmunol.0902055","article-title":"Minimal amino acid exchange in human TCR constant regions fosters improved function of TCR gene-modified T cells","volume":"184","author":"Sommermeyer","year":"2010","journal-title":"J. Immunol."},{"issue":"6181","key":"10.1016\/j.intimp.2020.106211_b0200","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/334395a0","article-title":"T-cell antigen receptor genes and T-cell recognition","volume":"334","author":"Davis","year":"1988","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2020.106211_b0205","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1074-7613(00)80599-3","article-title":"Individual variations in the murine T cell response to a specific peptide reflect variability in naive repertoires","volume":"9","author":"Bousso","year":"1998","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2020.106211_b0210","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical role for CD103(+)\/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2020.106211_b0215","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13073-015-0248-x","article-title":"Profiling tissue-resident T cell repertoires by RNA sequencing","volume":"7","author":"Brown","year":"2015","journal-title":"Genome Med."},{"issue":"9255","key":"10.1016\/j.intimp.2020.106211_b0220","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2020.106211_b0225","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.immuni.2018.06.006","article-title":"Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy","volume":"49","author":"Li","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2020.106211_b0230","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.3389\/fimmu.2018.02324","article-title":"Molecular mechanisms directing migration and retention of natural killer cells in human tissues","volume":"9","author":"Castriconi","year":"2018","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2020.106211_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/cells7080108","article-title":"Chemokine receptors and exercise to tackle the inadequacy of T cell homing to the tumor site","volume":"7","author":"Idorn","year":"2018","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.intimp.2020.106211_b0240","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10456-013-9407-0","article-title":"Control of dendritic cell trafficking in lymphatics by chemokines","volume":"17","author":"Johnson","year":"2013","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.intimp.2020.106211_b0245","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1189\/jlb.1A0314-170R","article-title":"The chemotaxis of M1 and M2 macrophages is regulated by different chemokines","volume":"97","author":"Xuan","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2020.106211_b0250","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.phrs.2017.02.026","article-title":"The role of chemokines in hypertension and consequent target organ damage","volume":"119","author":"Rudemiller","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.intimp.2020.106211_b0255","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1586\/17474124.2.2.233","article-title":"Chemokine-directed immune cell infiltration in acute and chronic liver disease","volume":"2","author":"Karlmark","year":"2008","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106211_b0260","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10549-013-2811-8","article-title":"CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis","volume":"143","author":"Biswas","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"issue":"13","key":"10.1016\/j.intimp.2020.106211_b0265","first-page":"1916","article-title":"Expression features of CXCR5 and its ligand, CXCL13 associated with poor prognosis of advanced colorectal cancer","volume":"18","author":"Qi","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2020.106211_b0270","first-page":"11","article-title":"Tumor-associated macrophages: effectors of angiogenesis and tumor progression","volume":"1796","author":"Coffelt","year":"2009","journal-title":"Biochim. Biophys. Acta"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919328164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919328164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:44:01Z","timestamp":1762551841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919328164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":54,"alternative-id":["S1567576919328164"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106211","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-tumor immune response varies among individuals: A gene expression profiling of mouse melanoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106211"}}